A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
Currently, there are no treatments or vaccines against Epstein-Barr virus (EBV) infection. Here, Zhu et al. isolate gH/gL-specific antibodies from infected donors and identify 1D8, that substantially reduces infection levels in both, B- and epithelial cells, and reduces tumor burdens in EBV-challang...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/2239cf6967614df582f09b6994a16020 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|